Analysis of operative morbidity in a single center initial experience with cytoreductive surgery and hyperthermic intraperitoneal chemotherapy.

PubWeight™: 0.82‹?›

🔗 View Article (PMID 24675485)

Published in Tumori on March 28, 2014

Authors

Luigina Graziosi, Elvira Mingrone, Elisabetta Marino, Emanuel Cavazzoni, Annibale Donini

Articles by these authors

A randomized study on 1-week versus 4-week prophylaxis for venous thromboembolism after laparoscopic surgery for colorectal cancer. Ann Surg (2014) 3.43

Early improvement of glucose tolerance after ileal transposition in a non-obese type 2 diabetes rat model. Obes Surg (2005) 1.53

How the hindgut can cure type 2 diabetes. Ileal transposition improves glucose metabolism and beta-cell function in Goto-kakizaki rats through an enhanced Proglucagon gene expression and L-cell number. Surgery (2007) 1.49

Targeting farnesoid X receptor for liver and metabolic disorders. Trends Mol Med (2007) 1.23

The enteroinsular axis and the recovery from type 2 diabetes after bariatric surgery. Obes Surg (2004) 1.12

The bile acid receptor GPBAR-1 (TGR5) modulates integrity of intestinal barrier and immune response to experimental colitis. PLoS One (2011) 1.11

Probiotics modulate intestinal expression of nuclear receptor and provide counter-regulatory signals to inflammation-driven adipose tissue activation. PLoS One (2011) 1.08

Malignant ascites: pathophysiology and treatment. Int J Clin Oncol (2012) 1.06

Gastric cancer and synchronous hepatic metastases: is it possible to recognize candidates to R0 resection? Ann Surg Oncol (2014) 1.01

Peritoneal sarcomatosis: is there a subset of patients who may benefit from cytoreductive surgery and hyperthermic intraperitoneal chemotherapy? Ann Surg Oncol (2010) 0.98

Dissociation of intestinal and hepatic activities of FXR and LXRα supports metabolic effects of terminal ileum interposition in rodents. Diabetes (2013) 0.97

The methionine connection: homocysteine and hydrogen sulfide exert opposite effects on hepatic microcirculation in rats. Hepatology (2008) 0.96

Isolation of human hepatocytes from livers rejected for liver transplantation on a national basis: results of a 2-year experience. Liver Transpl (2003) 0.95

Portal vein thrombosis after intraportal hepatocytes transplantation in a liver transplant recipient. Transpl Int (2005) 0.93

Effect of duodenal-jejunal exclusion in a non-obese animal model of type 2 diabetes: a new perspective for an old disease. Ann Surg (2004) 0.90

Do perioperative blood transfusions influence prognosis of gastric cancer patients? Analysis of 927 patients and interactions with splenectomy. Ann Surg Oncol (2011) 0.88

Successful palliation of malignant ascites from peritoneal mesothelioma by laparoscopic intraperitoneal hyperthermic chemotherapy. Surg Laparosc Endosc Percutan Tech (2008) 0.87

Emerging role of transplantation for primary liver cancers. Cancer J (2004) 0.87

Laparoscopic treatment of liver hemangioma. Surg Laparosc Endosc Percutan Tech (2005) 0.86

Prognostic value of the seventh AJCC/UICC TNM classification of non-cardia gastric cancer. World J Surg Oncol (2013) 0.85

Targeting FXR in cholestasis: hype or hope. Expert Opin Ther Targets (2014) 0.85

Gastrointestinal stromal tumours: evaluation of biological and clinical current opinions. Chir Ital (2002) 0.85

Laparoscopic treatment of a solitary fibrous tumor of the greater omentum presenting as spontaneous haemoperitoneum. Ann Ital Chir (2006) 0.84

Identification of a subgroup of patients at highest risk for complications after surgical cytoreduction and hyperthermic intraperitoneal chemotherapy. Ann Surg (2012) 0.84

A diagnosis of pneumococcal peritonitis secondary to pyo-salpinx in a young healthy female by culturing peritoneal pus. New Microbiol (2008) 0.83

Mechanistic role of p38 MAPK in gastric cancer dissemination in a rodent model peritoneal metastasis. Eur J Pharmacol (2011) 0.83

The SIC-GIRCG 2013 Consensus Conference on Gastric Cancer. Updates Surg (2014) 0.83

Role of FDG-PET/CT in follow-up of patients treated with resective gastric surgery for tumour. Ann Ital Chir (2011) 0.79

Role of CRS plus HIPEC in gastric cancer peritoneal carcinomatosis. J Surg Oncol (2014) 0.79

The Italian Registry of Laparoscopic Surgery of the Spleen (IRLSS) A retrospective review of 379 patients undergoing laparoscopic splenectomy. Chir Ital (2006) 0.79

Bile acid activated receptors are targets for regulation of integrity of gastrointestinal mucosa. J Gastroenterol (2015) 0.79

Naso-gastric or naso-jejunal decompression after partial distal gastrectomy for gastric cancer. Final results of a multicenter prospective randomized trial. Gastric Cancer (2013) 0.78

Epigenetic modulation by methionine deficiency attenuates the potential for gastric cancer cell dissemination. J Gastrointest Surg (2012) 0.78

First report of cryopreserved human hepatocytes based bioartificial liver successfully used as a bridge to liver transplantation. Am J Transplant (2004) 0.78

Bowel necrosis associated with early jejunal tube feeding. Arch Surg (2007) 0.78

Appendicectomy and Crohn's disease: clinical and genetic associations. Gastroenterology (2003) 0.77

[Postoperative follow-up of gastric adenocarcinoma with neoplastic markers and 18-FDG-PET/TC]. Ann Ital Chir (2008) 0.77

Gene expression changes induced by HIPEC in a murine model of gastric cancer. In Vivo (2012) 0.76

Implication of stem cell factor in human liver regeneration after transplantation and resection. Growth Factors (2006) 0.76

Recurrence of retroperitoneal Merkel cell carcinoma. A case report. Ann Ital Chir (2014) 0.76

Preliminary results of prophylactic HIPEC in patients with locally advanced gastric cancer. Ann Ital Chir (2013) 0.76

The role of steatosis of the liver graft in the development of post-transplant biliary complications. Transpl Int (2009) 0.76

Transvaginal laparoscopically assisted endoscopic cholecystectomy: report of 3 cases. Gastrointest Endosc (2008) 0.75

Human hepatocyte isolation for liver cell therapy: whole marginal livers or healthy segments from splitting? Transplantation (2005) 0.75

Bile leak from the hepatic bed after laparoscopic cholecystectomy. Chir Ital (2002) 0.75

Activin A: a possible marker for liver transplant outcome. Growth Factors (2004) 0.75

Hepatic artery ligation for arterio-duodenal fistula secondary to fistulisation of a hepato-hepatic by-pass into the duodenum. Chir Ital (2006) 0.75

Laparoscopic cholecystectomy for a symptomatic cholelithiasis in a patient presenting situs viscerum inversus totalis. A case report. Ann Ital Chir (2012) 0.75

Sepsis from spontaneous vesicocutaneous fistula. Surg Infect (Larchmt) (2012) 0.75

[Preliminary experience on the application of metallic stents for treatment of colorectal malignant stenosis]. Ann Ital Chir (2009) 0.75

Ileosplenic fistula and splenic abscesses caused by migration of biliary stents in a liver transplant recipient. Gastrointest Endosc (2003) 0.75

Late retransplantation of the liver: a single-centre experience. Chir Ital (2006) 0.75

Hyperthermic intraperitoneal chemotherapy as palliative treatment for malignant ascites A single-center experience and a review of the literature. Ann Ital Chir (2016) 0.75